Text Size

Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Deciphera Pharmaceuticals LLC
ClinicalTrials.gov Identifier:
NCT00827138
First received: January 21, 2009
Last updated: October 25, 2012
Last verified: October 2012
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
No publications provided by Deciphera Pharmaceuticals LLC

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):